logo

For the Inventor, By the Inventor

Houston, TX, United States of America

Bharat B Aggarwal

This inventor holds 26 USPTO granted patents, plus 1 CIPO patent, primarily in Cancer Treatment. Top assignees: Research Development Foundation, The University of Texas System, New Chapter Inc.. Active years: 1993-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bharat B Aggarwal. Retrieved from https://idiyas.com/inventor/bharat-b-aggarwal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 26

% Patents Active = 65.4


Average Co-Inventor Count = 1.6

ph-index = 8

Forward Citations = 181(Granted Patents)


Company Filing History:

goldMedal19 out of 299 
 
Research Development Foundation
 patents
silverMedal4 out of 5,644 
 
The University of Texas System
 patents
bronzeMedal3 out of 13 
 
New Chapter Inc.
 patents
4. 2 out of 44 
 
Research Development Corporation
 patents
5. 1 out of 1 
 
Universidad Autonoma De Nievo Leon
 patent
6. 1 out of 3 
 
Universidad Autonoma De Nuevo León
 patents
where one patent can have more than one assignee

Years Active: 1993-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Curcumin
Cancer Treatment
Eicosanoid Metabolism
NF-kB Inhibitors
Osteoclastogenesis
Apoptosis
Multiple Myeloma
Cytokines
Oncoinhibin
Tumor Necrosis Factor
Protein Sequence
Antiproliferative Agents
26 patents (USPTO):Explore Patents
1. 10182997 - Liposomal curcumin for treatment of cancer (2019-01-22),
2. 9283185 - Liposomal curcumin for treatment of cancer (2016-03-15),
3. 8252345 - Methods for modulating eicosanoid metabolism (2012-08-28),
4. 8114446 - Methods for modulating eicosanoid metabolism (2012-02-14),
5. 7563462 - Methods for modulating eicosanoid metabolism (2009-07-21),
6. 7462646 - Osteoclastogenesis inhibitors and uses thereof (2008-12-09),
7. 7368430 - Selective inhibitors of nuclear factor-κB activation and uses thereof (2008-05-06),
8. 7241576 - Uses of THANK, a TNF homologue that activates apoptosis (2007-07-10),
9. 7196105 - Treatment of human multiple myeloma by curcumin (2007-03-27),
10. 7105576 - Synergistic effects of nuclear transcription factor NF-κB inhibitors and anti-neoplastic agents (2006-09-12),
11. 6998383 - Inhibitors of receptor activator of NF-κB and uses thereof (2006-02-14),
12. 6605278 - Uses of trank, a novel secretory cytokine (2003-08-12),
13. 6475986 - Uses of THANK, a TNF homologue that activates apoptosis (2002-11-05),
14. RE37462 - Protein sequence of the plant toxin gelonin (2001-12-04),
15. 5993798 - Oncoinhibin and methods of pharmaceutical use (1999-11-30),

Title: Bharat B Aggarwal: Innovator in Cancer Treatment

Introduction

Bharat B Aggarwal, based in Houston, TX, is a prominent inventor known for his significant contributions to cancer treatment through innovative drug delivery systems. With a robust portfolio of 26 patents, Aggarwal has made notable advancements in the field of medicinal chemistry and pharmacology.

Latest Patents

One of his latest inventions involves the development of liposomal curcumin for the treatment of cancer. This innovation provides compositions and methods aimed at treating various forms of cancer, including pancreatic cancer, breast cancer, and melanoma. The invention utilizes curcumin or a curcumin analog encapsulated in a colloidal drug delivery system, with a preference for a liposomal format. Other suitable delivery systems mentioned include nanoparticles, nanocapsules, microparticles, and block copolymer micelles. These systems allow for the parenteral administration of the encapsulated curcumin in a pharmaceutically acceptable carrier, enhancing its potential efficacy against cancer.

Career Highlights

Aggarwal has made significant strides in his career by working with reputable organizations such as the Research Development Foundation and New Chapter Inc. His work in these companies has solidified his role as an influential figure in cancer research and development.

Collaborations

Throughout his career, Aggarwal has collaborated with esteemed professionals, including Thomas Newmark and Paul Schulick. These partnerships have fostered innovation and the advancement of his research in the field of cancer treatment.

Conclusion

Bharat B Aggarwal stands out as a pioneer in the medical field, particularly in the development of novel treatments for cancer. His innovative approaches and extensive patent portfolio reflect his commitment to improving patient outcomes and advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…